DIN 02530546 — EYEZIRGAN 0.15 %
EYEZIRGAN is a gel of Ganciclovir marketed by LABORATOIRES THEA. The full Ganciclovir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02530546
- Brand name
- EYEZIRGAN
- Active ingredient
- Ganciclovir
- Strength
- 0.15 %
- Dosage form
- GEL
- Route
- OPHTHALMIC
- Manufacturer
- LABORATOIRES THEA
- Health Canada status
- MARKETED
- Drug class
- Antiviral agent (synthetic nucleoside analogue)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ganciclovir products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02162695 | CYTOVENE | 500 MG | POWDER FOR SOLUTION | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED |
| 02537168 | GANCICLOVIR FOR INJECTION | 500 MG | POWDER FOR SOLUTION | FORMATIVE PHARMA INC. | MARKETED |
| 02475391 | GANCICLOVIR FOR INJECTION USP | 500 MG | POWDER FOR SOLUTION | STERIMAX INC | MARKETED |
| 02404761 | GANCICLOVIR FOR INJECTION, USP | 500 MG | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |